Ignite Creation Date:
2025-12-24 @ 3:20 PM
Ignite Modification Date:
2025-12-27 @ 6:42 PM
Study NCT ID:
NCT04434092
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-11-10
First Post:
2020-06-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-06-03
First Submit QC Date:
None
Study First Post Date:
2020-06-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-09-15
Results First Submit QC Date:
None
Results First Post Date:
2025-11-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-11-10
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2025-10-28
Last Update Post Date:
2025-11-10
Last Update Post Date Type:
ESTIMATED